Rare diseases
Investigational molecules
Locations
3031 Tisch Way Ste 505, 95128-2531, United States
Cessation Therapeutics Inc. focuses on clinical research in opioid use disorder, with particular attention to the respiratory complications associated with fentanyl exposure and opioid-induced respiratory depression.
The sponsor’s current research activity is centered on understanding how opioid exposure affects breathing control in both healthy adults and participants with opioid use disorder.
Cessation Therapeutics Inc. runs clinical trials in conditions such as Drug use disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
The NetherlandsIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
